Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 125, Issue 18
April 30 2015
Issue Cover

Table of Contents

BLOOD COMMENTARIES

INSIDE BLOOD COMMENTARY
IL-13 as a novel growth factor in CTCL
Mariusz A. Wasik
View Articletitled, IL-13 as a novel growth factor in CTCL
INSIDE BLOOD COMMENTARY
INPP4B, a new player in the chemoresistance of AML
Christian Recher
View Articletitled, INPP4B, a new player in the chemoresistance of AML
INSIDE BLOOD COMMENTARY
Toward a BETter grasp of acetyl-lysine readers
Catherine Porcher
View Articletitled, Toward a BETter grasp of acetyl-lysine readers
INSIDE BLOOD COMMENTARY
HLA class II meets β2-glycoprotein I
Perumal Thiagarajan
View Articletitled, HLA class II meets β<sub>2</sub>-glycoprotein I
INSIDE BLOOD COMMENTARY
A maturing understanding of naive T cells
Krishna V. Komanduri
View Articletitled, A maturing understanding of naive T cells

BLOOD FORUM

Planning for the future workforce in hematology research
W. Keith Hoots,Janis L. Abkowitz,Barry S. Coller,Donna M. DiMichele
View Articletitled, Planning for the future workforce in hematology research

BLOOD SPOTLIGHT

JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities
Clinical Trials & Observations
Katherine R. Calvo,Susan Price,Raul C. Braylan,Joao Bosco Oliveira,Michael Lenardo,Thomas A. Fleisher,V. Koneti Rao
View Articletitled, JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities
Supplemental data

HOW I TREAT

How I treat postpartum hemorrhage
Sue Pavord,Helena Maybury
View Articletitled, How I treat postpartum hemorrhage

CLINICAL TRIALS AND OBSERVATIONS

Phase 3 study of nilotinib vs imatinib in Chinese patients with newly diagnosed chronic myeloid leukemia in chronic phase: ENESTchina
Clinical Trials & Observations
Jianxiang Wang,Zhi-Xiang Shen,Giuseppe Saglio,Jie Jin,He Huang,Yu Hu,Xin Du,Jianyong Li,Fanyi Meng,Huanling Zhu,Jianda Hu,Jianmin Wang,Ming Hou,Sabine Hertle,Hans D. Menssen,Christine-Elke Ortmann,Catherine Tribouley,Ye Yuan,Michele Baccarani,Xiaojun Huang
View Articletitled, Phase 3 study of nilotinib vs imatinib in Chinese patients with newly diagnosed chronic myeloid leukemia in chronic phase: ENESTchina
Obinutuzumab plus fludarabine/cyclophosphamide or bendamustine in the initial therapy of CLL patients: the phase 1b GALTON trial
Clinical Trials & Observations
Jennifer R. Brown,Susan O’Brien,C. Daniel Kingsley,Herbert Eradat,John M. Pagel,James Lymp,Jamie Hirata,Thomas J. Kipps
View Articletitled, Obinutuzumab plus fludarabine/cyclophosphamide or bendamustine in the initial therapy of CLL patients: the phase 1b GALTON trial

HEMATOPOIESIS AND STEM CELLS

IP3 3-kinase B controls hematopoietic stem cell homeostasis and prevents lethal hematopoietic failure in mice
Sabine Siegemund,Stephanie Rigaud,Claire Conche,Blake Broaten,Lana Schaffer,Luise Westernberg,Steven Robert Head,Karsten Sauer
View Articletitled, IP<sub>3</sub> 3-kinase B controls hematopoietic stem cell homeostasis and prevents lethal hematopoietic failure in mice
Supplemental data

LYMPHOID NEOPLASIA

Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation
Larisa J. Geskin,Sara Viragova,Donna B. Stolz,Patrizia Fuschiotti
View Articletitled, Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation
Supplemental data
Therapeutic targeting of HES1 transcriptional programs in T-ALL
Stephanie A. Schnell,Alberto Ambesi-Impiombato,Marta Sanchez-Martin,Laura Belver,Luyao Xu,Yue Qin,Ryoichiro Kageyama,Adolfo A. Ferrando
View Articletitled, Therapeutic targeting of HES1 transcriptional programs in T-ALL
Supplemental data

MYELOID NEOPLASIA

Inositol polyphosphate 4-phosphatase II (INPP4B) is associated with chemoresistance and poor outcome in AML
Clinical Trials & Observations
Sewa Rijal,Shaun Fleming,Nik Cummings,Natalie K. Rynkiewicz,Lisa M. Ooms,Nhu-Y. N. Nguyen,Tse-Chieh Teh,Sharon Avery,Julie F. McManus,Anthony T. Papenfuss,Catriona McLean,Mark A. Guthridge,Christina A. Mitchell,Andrew H. Wei
View Articletitled, Inositol polyphosphate 4-phosphatase II (INPP4B) is associated with chemoresistance and poor outcome in AML
Supplemental data

RED CELLS, IRON, AND ERYTHROPOIESIS

Functions of BET proteins in erythroid gene expression
Aaron J. Stonestrom,Sarah C. Hsu,Kristen S. Jahn,Peng Huang,Cheryl A. Keller,Belinda M. Giardine,Stephan Kadauke,Amy E. Campbell,Perry Evans,Ross C. Hardison,Gerd A. Blobel
View Articletitled, Functions of BET proteins in erythroid gene expression
Supplemental data

THROMBOSIS AND HEMOSTASIS

β2-Glycoprotein I/HLA class II complexes are novel autoantigens in antiphospholipid syndrome
Kenji Tanimura,Hui Jin,Tadahiro Suenaga,Satoko Morikami,Noriko Arase,Kazuki Kishida,Kouyuki Hirayasu,Masako Kohyama,Yasuhiko Ebina,Shinsuke Yasuda,Tetsuya Horita,Kiyoshi Takasugi,Koichiro Ohmura,Ken Yamamoto,Ichiro Katayama,Takehiko Sasazuki,Lewis L. Lanier,Tatsuya Atsumi,Hideto Yamada,Hisashi Arase
View Articletitled, β2-Glycoprotein I/HLA class II complexes are novel autoantigens in antiphospholipid syndrome
Supplemental data
EPCR-dependent PAR2 activation by the blood coagulation initiation complex regulates LPS-triggered interferon responses in mice
Hai Po H. Liang,Edward J. Kerschen,Irene Hernandez,Sreemanti Basu,Mark Zogg,Fady Botros,Shuang Jia,Martin J. Hessner,John H. Griffin,Wolfram Ruf,Hartmut Weiler
View Articletitled, EPCR-dependent PAR2 activation by the blood coagulation initiation complex regulates LPS-triggered interferon responses in mice
Supplemental data

TRANSPLANTATION

Role of naive-derived T memory stem cells in T-cell reconstitution following allogeneic transplantation
Alessandra Roberto,Luca Castagna,Veronica Zanon,Stefania Bramanti,Roberto Crocchiolo,James E. McLaren,Sara Gandolfi,Paolo Tentorio,Barbara Sarina,Inna Timofeeva,Armando Santoro,Carmelo Carlo-Stella,Benedetto Bruno,Cristiana Carniti,Paolo Corradini,Emma Gostick,Kristin Ladell,David A. Price,Mario Roederer,Domenico Mavilio,Enrico Lugli
View Articletitled, Role of naive-derived T memory stem cells in T-cell reconstitution following allogeneic transplantation
Supplemental data
Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation
Nicoletta Cieri,Giacomo Oliveira,Raffaella Greco,Mattia Forcato,Cristian Taccioli,Beatrice Cianciotti,Veronica Valtolina,Maddalena Noviello,Luca Vago,Attilio Bondanza,Francesca Lunghi,Sarah Marktel,Laura Bellio,Claudio Bordignon,Silvio Bicciato,Jacopo Peccatori,Fabio Ciceri,Chiara Bonini
View Articletitled, Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation
Supplemental data

BLOOD WORK

Neoplastic plasma cells mimic mature neutrophils in plasma cell myeloma with t(11;14)(q13;q32)
Wei Wang,Shimin Hu
View Articletitled, Neoplastic plasma cells mimic mature neutrophils in plasma cell myeloma with t(11;14)(q13;q32)
  • Cover Image

    Cover Image

    issue cover

    Interleukin-13 (IL-13) and its receptors represent novel markers of cutaneous T-cell lymphoma (CTCL). Immunofluorescence staining reveals CD4+ cells (green) in the tumor infiltrate of CTCL skin that coexpress IL-13Rα1 (red). IL-13 induces CTCL cell growth in vitro and signals through IL-13Rα1. Nuclei are identified by 4,6 diamidino-2-phenylindole (blue). See the article by Geskin et al on page 2798.

  • PDF Icon PDF LinkFront Matter
  • PDF Icon PDF LinkTable of Contents
  • PDF Icon PDF LinkBack Matter
  • PDF Icon PDF LinkEditorial Board
All Issues

Advertisement intended for health care professionals

For how long has this problem been there?
Targeting CD47: many misses; hopeful for a hit
Woyach JA, Burbano GP, Ruppert AS, et al. Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL. Blood. 2024;143(16):1616-1627.
MRD-guided zanubrutinib, venetoclax and obinutuzumab in relapsed CLL: primary endpoint analysis from the CLL2-BZAG trial
Sickle Cell Trait Does Not Cause "Sickle Cell Crisis" Leading to Exertion-Related Death: A Systematic Review

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals